Mirum Pharmaceuticals, Inc. (MIRM)
NASDAQ: MIRM · Real-Time Price · USD
47.98
+1.03 (2.19%)
At close: Jan 21, 2025, 4:00 PM
50.37
+2.39 (4.98%)
After-hours: Jan 21, 2025, 4:15 PM EST
Mirum Pharmaceuticals Employees
Mirum Pharmaceuticals had 264 employees as of December 31, 2023. The number of employees increased by 68 or 34.69% compared to the previous year.
Employees
264
Change (1Y)
68
Growth (1Y)
34.69%
Revenue / Employee
$1,162,985
Profits / Employee
-$378,072
Market Cap
2.30B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 89,900 |
Novartis AG | 76,057 |
Merck & Co. | 72,000 |
Novo Nordisk | 64,319 |
MIRM News
- 8 days ago - Mirum Pharmaceuticals Announces Preliminary Unaudited 2024 Net Product Sales and Cash Balance and Provides Corporate Updates - Business Wire
- 11 days ago - Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 13 days ago - Top 5 Commercial Biotech Buyout Candidates: Mirum Pharmaceuticals (No. 3) - Seeking Alpha
- 15 days ago - Mirum Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference - Business Wire
- 27 days ago - Mirum Pharma: Buy At Dips For Volixibat Potential - Seeking Alpha
- 2 months ago - Mirum Pharmaceuticals to Showcase Data from its LIVMARLI and Volixibat Clinical Programs at AASLD's The Liver Meeting - Business Wire
- 2 months ago - Mirum Pharmaceuticals, Inc. (MIRM) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Mirum Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Business Update - Business Wire